TMQ.TO
Trilogy Metals Inc.Loading price…
Loading price…
4 active warrant series; nearest expiry 2026-11-30.
Compare this book against every issuer →4 option grants covering 9,835,250 shares (~5.7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $2.21 | Nov 30, 2026 78d | 1.1M | ITM | 0.7% | C$2.5M | Auto |
| option | $0.69 | May 31, 2028 626d | 5.1M | ITM | 3.0% | C$3.5M | Auto |
| option | $1.52 | Nov 30, 2029 1174d | 1.9M | ITM | 1.1% | C$2.9M | Auto |
| option | $6.53 | May 31, 2031 1721d | 1.7M | OTM | 1.0% | C$10.8M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
172,745,639 shares outstanding, plus 0 from warrants and 9,835,250 from options — a fully diluted 182,580,889 shares, or ~5.7% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
4 active warrant series; nearest expiry 2026-11-30.
Compare this book against every issuer →4 option grants covering 9,835,250 shares (~5.7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $2.21 | Nov 30, 2026 78d | 1.1M | ITM | 0.7% | C$2.5M | Auto |
| option | $0.69 | May 31, 2028 626d | 5.1M | ITM | 3.0% | C$3.5M | Auto |
| option | $1.52 | Nov 30, 2029 1174d | 1.9M | ITM | 1.1% | C$2.9M | Auto |
| option | $6.53 | May 31, 2031 1721d | 1.7M | OTM | 1.0% | C$10.8M | Auto |
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
172,745,639 shares outstanding, plus 0 from warrants and 9,835,250 from options — a fully diluted 182,580,889 shares, or ~5.7% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
